Two cases of fatal virus-associated hemophagocytic syndrome (VAHS) were reported.
Division of Infection, Immunology and Rheumatology, Kanagawa Children's Medical Center [Summary] Two cases of fatal virus-associated hemophagocytic syndrome (VAHS) were reported.
Case 1. A 2-year-old boy was admitted to our hospital with hepatic failure and sepsis.
Bone marrow examination revealed typical hemophagocytes, and both EBV VCA-IgM and EBNA were negative. Despite the combined administration of antiviral agents, interferon alpha, high dose of y-globulin and liposteroid, the patient rapidly developed multiple organ failure and died after a total clinical course of 37 days. The autopsy showed that all of the organs examined were infiltrated with atypical lymphoid cells with prominent necrosis. The EBV genome was demonstrated in the lymphoid tissue, kidneys and salivary glands by Southern hybridization technique.
Case 2. A 2-year-old girl was refered to our hospital with persistent high fever of unknown origin. The laboratory examination revealed anemia, leukopenia and abnormal liver function tests on admission, and deteriorated to typical signs of VAHS. Interstitial pneumonia appeared and she was treated with high-dose r-globulin and methylprednisolone pulses. However, respiratory failure was progressed. Lung biopsy revealed giant-cell pneu monia, and measles virus was detected in the viral culture despite the lack of skin rashes.
The immunosuppressants, VP-16 and liposteroid, were administered to the patient, but failured.
They manifested similar clinical course and the etiologic agent were varied. Since the pathophysiology of VAHS is believed to be immunologically a hyper reactive status to the infected virus, the immunosuppressive therapy was employed, but failed. The im munological mechanism of VAHS should be investigated.
